Alström syndrome: clinical signs and treatment.

  • Dania Aguilar Suárez Universidad Regional Autónoma de Los Andes
  • Sara Del Rocío De Mora Rosero Universidad Regional Autónoma de Los Andes
  • Nohely Gabriela Espinoza Macías Universidad Regional Autónoma de Los Andes
Keywords: Molecular studies, alternatives, specific treatment, ALMS1 gene

Abstract

This is a monogenic syndrome caused by mutations in the ALMS1 gene, characterized by progressive multiorgan damage that can lead to premature death. The general objective of this research is to be able to investigate the different clinical aspects of Alström syndrome and thus identify diagnostic guidelines and alternative therapies. This work was carried out using the descriptive observational study methodology and several reviews of bibliographic data were carried out through the internet. It was concluded that Alström syndrome does not have a specific treatment, but there are different alternatives that help manage this condition, through molecular studies, which help its diagnosis.

References

Bea-Mascato, B., Solarat, C., Perea-Romero, I., Jaijo, T., Blanco-Kelly, F., Millán, J. M., & Valverde, D. (2021). Prevalent ALMS1 pathogenic variants in Spanish Alström patients. Genes, 12(2), 282. https://www.mdpi.com/2073-4425/12/2/282/pdf?version=1614326190

Carvalho, I. (2022). Síndrome de Alström familiar: série de casos. (tesis de grado de la Universidad de Brasilia). https://repositorio.unb.br/handle/10482/43741

Colunga, S., Velasco, E., Corros, C., Martín, M., García, L., & Tassa, C. (2018). Síndrome de Alström: una rara causa de miocardiopatía. Rev. esp. cardiol. (Ed. impr.), 71(4), 296-298. https://www.revespcardiol.org/es-pdf-S0300893217301112

Dassie, F., Favaretto, F., Bettini, S., Parolin, M., Valenti, M., Reschke, F., ... & Maffei, P. (2021). Alström syndrome: an ultra-rare monogenic disorder as a model for insulin resistance, type 2 diabetes mellitus and obesity. Endocrine, 71(3), 618-625. https://link.springer.com/article/10.1007/s12020-021-02643-y

Forsythe, E., & Beales, P. (2013). Bardet–Biedl syndrome. European journal of human genetics, 21(1), 8-13. https://www.nature.com/articles/ejhg2012115.pdf

Lozano, E. (2022). Resistencia a Insulina: Revisión de literatura. Revista Médica Hondureña, 90(1), 63-70. https://camjol.info/index.php/RMH/article/view/13824/17082

Marshall, J., Beck, S., Maffei, P., & Naggert, J. (2007). Alström syndrome. European Journal of Human Genetics, 15(12), 1193-1202. https://www.nature.com/articles/5201933.pdf

Real Academia Española. (2022). Definición de enfermedad. RAE. https://dle.rae.es/enfermedad?m=form

Sancan, B., & Cruz, D. (2021). Síndrome de Alström (OMIM 203800): Reporte del primer caso en Ecuador. Revista Medicina e Investigación Clínica Guayaquil, 2(3), 59-62. https://www.revistaclinicaguayaquil.org/index.php/revclinicaguaya/article/view/61/44

Zaloszyc, A., Schaefer, E., & Nobili, F. (2021). Ciliopatías. EMC-Pediatría, 56(3), 1-8. https://www.sciencedirect.com/science/article/abs/pii/S1245178921454843

Published
2022-12-01